Skip to main content
. 2018 Dec 19;316(3):F414–F425. doi: 10.1152/ajprenal.00167.2018

Table 2.

Oligonucleotides used for PKHD1 and PKD2 targeting

Mutation (cDNA) CRISPR gRNA Sequence
PKHD1
    c.126delT 3′-GTAGCCTTGCAGGGGGAACGTGG-5′
    c.711_714del 3′-CATGTGGAAGGCGACTACATCGG-5′
    c.1854delA 5′-TGAAGGACACAATCATCTTCAGG-3′
    c.3761_3762delCCinsG 5′-TGAAGGACACAATCATCTTCAGG-3′
    c.9689delA 5′-GCATCGGGTATCTGGGGGGCTGG-3′
PKD2
    c.958C>T 5′-ACTCGGAGTTGCCGTATTCGTGG-3′
    c.2224C>T 3′-GAACTTCGACAAGATCTCAAAGG-5′
    c.2407C>T 5′-CAGAGTCATCCAGGCTTCGAGGG-3′
    c.2419C>T 5′-CAGAGTCATCCAGGCTTCGAGGG-3′

Protospacer adjacent motifs are underlined. PKHD1, polycystic kidney and hepatic disease 1 gene; PKD2, polycystic kidney disease 2 gene; gRNA, guide RNA.